BOTHELL, Wash. (AP) — BOTHELL, Wash. (AP) — Seattle Genetics Inc. (SGEN) on Wednesday reported a loss of $215.8 million in its third quarter.
The Bothell, Washington-based company said it had a loss of $1.15 per share.
The results missed Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of 71 cents per share.
The biotechnology company posted revenue of $648.7 million in the period, beating Street forecasts. Six analysts surveyed by Zacks expected $640.2 million.
Advertisement
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on SGEN at https://www.zacks.com/ap/SGEN
Advertisement